![](/img/cover-not-exists.png)
Determining the value contribution of emicizumab (Hemlibra ® ) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Álvarez-Román, Maria Teresa, Cuervo-Arango, Ignacio, Pérez-Santamarina, Rafael, Poveda, José Luís, Romero, José Antonio, Santamaría, Amparo, Trillo-Mata, José Luís, Tort, Marina, Badia, XavierVolume:
2019
Language:
english
Journal:
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
DOI:
10.1177/2284240319880534
Date:
January, 2019
File:
PDF, 487 KB
english, 2019